Announcements
Sidley Represents EDBI in Automera’s US$16M Series A Financing
October 2, 2023
Sidley represented EDBI in its investment in Automera, a company developing an autophagy drug designed to target chimera small molecules (AUTACs), in its US$16M Series A financing round.
The round was co-led by U.S.-based Accelerator Life Sciences Partners (ALSP) and Temasek-backed ClavystBio, with participation of Xora Innovation and other investors.
The Sidley team was led by corporate partner Andrew Harper, and included private equity partner Parthiv Rishi, senior managing associate Eldon Chan, and associates Ryan Lim, and Yasmeen A. Sayyah.
The round was co-led by U.S.-based Accelerator Life Sciences Partners (ALSP) and Temasek-backed ClavystBio, with participation of Xora Innovation and other investors.
The Sidley team was led by corporate partner Andrew Harper, and included private equity partner Parthiv Rishi, senior managing associate Eldon Chan, and associates Ryan Lim, and Yasmeen A. Sayyah.
Contacts
Offices
Capabilities
Suggested News & Insights
2026 Emerging Companies & Venture Capital SummitWednesday, May 20, 2026International Emergency Economic Powers Act Tariff Refund Claims: Key Considerations for Lenders, Borrowers, and Claims PurchasersApril 30, 2026Chambers Global Practice Guides – Corporate M&A 2026April 24, 2026Sidley Represents Valius Sciences in Financing Raising More Than US$10 Million for Future Cancer DiagnosticsApril 23, 2026New U.S. SEC Exemptive Order on Tender Offers Will Meaningfully Streamline Certain Liquidity TransactionsApril 21, 2026Sidley Represents Galera Therapeutics in Its Merger With Obsidian Therapeutics and US$350 Million Private Placement FinancingApril 21, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory